Registry for managing outcomes in patients with atrial fibrillation
MANAGEment of Atrial Fibrillation Outcomes Registry (MANAGE-AF)
This study is creating a registry to track how patients with atrial fibrillation are treated and their outcomes, aiming to improve care and reduce the risk of complications like strokes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | CorVita Science Foundation Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Trial ID | NCT05978466 on ClinicalTrials.gov |
What this trial studies
This research aims to gather data on the management of patients diagnosed with atrial fibrillation (AF), a condition characterized by irregular heartbeats that increase the risk of stroke. The study will create a registry to track treatment patterns and outcomes, including the prevention of thrombo-embolic events and the effectiveness of various interventions. By documenting the natural history of AF and associated complications, the registry will help identify trends in patient care across different demographics and treatment approaches. The goal is to improve understanding and management of AF to enhance patient outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are adults diagnosed with either valvular or non-valvular atrial fibrillation.
Not a fit: Patients under 18 years old or those with a clinical prognosis of death within six months may not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could lead to improved management strategies for patients with atrial fibrillation, potentially reducing the risk of stroke and other complications.
How similar studies have performed: Other studies have successfully utilized registries to improve understanding and management of atrial fibrillation, indicating that this approach has potential for meaningful insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Diagnosis of valvular or non valvular atrial fibrillation 2. ECG documented atrial fibrillation A. 12 lead B. Rhythm strip C. Event monitor D. Holter Monitor E. Implantable loop recorder Exclusion Criteria: 1. Age below 18 years. 2. Clinical evidence that death within 6 months is possible 3. Inability to consent to the research or sign a consent form 4. Inability to follow up at the research clinic at least annually for continuity of AF care and management
Where this trial is running
Chicago, Illinois
- CorVita Science Foundation (NFP) — Chicago, Illinois, United States (Recruiting)
Study contacts
- Principal investigator: Martin C Burke, DO — Chief Scientific Officer
- Study coordinator: Edward M Burke
- Email: eddie@corvitahealth.org
- Phone: 773-432-4888
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.